Armenia vs Belarus: Average cost of drugs for extensively drug-resistant tuberculosis
Armenia
4,190 constant 2022 US$
in 2024
Belarus
4,600 constant 2022 US$
in 2023
Armenia rank
16th
Belarus rank
13th
Average cost of drugs for extensively drug-resistant tuberculosis over time
- Armenia
- Belarus
How they compare
Belarus currently reports 4,600 constant 2022 US$ against 4,190 constant 2022 US$ in Armenia, a difference of 410 constant 2022 US$.
That makes Belarus's figure about 1.1 times Armenia's.
Armenia ranks 16th and Belarus ranks 13th of 56 countries.
Belarus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Armenia | Belarus | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4,900 constant 2022 US$ | 7,650 constant 2022 US$ | 2,750 constant 2022 US$ | Belarus |
| 2020s | 5,600 constant 2022 US$ | 5,867 constant 2022 US$ | 266.67 constant 2022 US$ | Belarus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of drugs for extensively drug-resistant tuberculosis, Armenia or Belarus?
- Belarus, at 4,600 constant 2022 US$ against 4,190 constant 2022 US$ in Armenia as of 2023.
- What is the difference in average cost of drugs for extensively drug-resistant tuberculosis between Armenia and Belarus?
- 410 constant 2022 US$, with Belarus ahead.
- How do Armenia and Belarus rank globally for average cost of drugs for extensively drug-resistant tuberculosis?
- Armenia ranks 16th and Belarus ranks 13th of 56 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.